Considerations in Planning Vegan Diets: Infants
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Frequently Asked Questions About Prebiotics and Probiotics
Frequently Asked Questions about Prebiotics and Probiotics February 2015 In recent years many baby food companies have advertised that they have added pre and probiotics to their formulas and baby foods. What do we actually know about these additives and is the intensive promotion of products which contain them really justified? Q1: What are prebiotics and probiotics? The origin of the term is the Greek word Bios, meaning life or living organisms. The prefix ‘pre’ means coming before and ‘pro’ means supporting. Prebiotics thus prepare the way for the Probiotics - the live beneficial bacteria which are naturally found in our bodies. Prebiotics are commonly called ‘food for bugs’. Prebiotics are the fiber compounds that pass through the upper part of the digestive tract. Because they are not digested by humans they act instead as a food source to help the essential beneficial bacteria grow and multiply in the infant’s gut. Prebiotics are thus not probiotic bacteria, but provide a substrate serving instead to stimulate the growth and activity of the beneficial probiotic bacteria. Probiotics is the term used for these friendly and harmless bacteria which help move food through the body and fight off all the harmful bacteria that can invade the infant’s gut – the digestive system and small and large intestines. Probiotics colonize the large bowel or colon influence and thus inhibit the growth of harmful bacteria, helping to improve digestion and enhance mineral absorption as well as to strengthen the baby’s immune system. In short, pre and probiotics reduce the ‘bad bacteria’ and increase the ‘good bacteria’ in the gut. -
The Book Collection at the Veggie Center FAR from COMPLETE, THIS LIBRARY of VEGETARIAN SOURCES SHOWS the BREADTH of OUR CULTURE
2 WHAT YOU’LL FIND AT THE VEGETARIAN CENTER OF NYC: A RESOURCE GUIDE The Vegetarian Center is the If you’re a vegetarian, we’ve brightest jewel in VivaVegie’s got the answers! education and outreach crown. The Vegetarian Center of NYC is a unique clearinghouse for information. On a daily basis, it receives numerous The VivaVegie Society has a solid history of service to phone calls and walk-in visits from inquisitive people in- the vegetarian community. Since 1991 it has distributed terested in the vegetarian lifestyle. People are always tens of thousands of copies of its hallmark publication, grateful for what the center has to offer them, usually “101 Reasons Why I’m a Vegetarian” by Pamela free of charge. Rice. It has continuously published its journal, The Viva- Vine, for over 10 years. It has been tireless in its dedication This place is here for you. to creative and effective vegetarian street outreach. Hun- Today we vegetarians have a place to call home—a fa- dreds of people, and perhaps thousands, have adopted cility that is there strictly on our behalf. In the long run, the vegetarian lifestyle because of the efforts of the group. the center will grow into whatever the vegetarian com- VivaVegie’s proudest accomplishment, however, has munity of New York City decides it should be. VivaVegie been the opening of its Vegetarian Center. Here is a has laid a foundation. The challenge for us as a com- place that focuses on projecting the vegetarian point of munity is to come together and build this center into a view as its primary mission. -
Volume 12 2016-2017
DIALOGUES@RU EDITORIAL BOARD SPRING 2017 FALL 2017 Emily Bliss Kelly Allen Lingyi Chen Amy Barenboim Wendy Chen Dustin He Steven Land Wei Yen Heng Kimberly Livingston Devika Kishore Valerie Mayzelshteyn Jasminy Martinez Daphne Millard Shannon McIntyre Keoni Nguyen Michele Mesi Ilana Shaiman Kalina Nissen Chad Stewart Jillian Pastor Abigail Stroebel Kassandra Rhoads Yashi Yadav Syeda Saad Cheyenne Terry Aurora Tormey EDITORS Tracy Budd Lynda Dexheimer COVER DESIGN & TYPESETTING Mike Barbetta © Copyright 2017 by Dialogues@RU All rights reserved. Printed in U.S.A. ii. CONTENTS Foreword • v Natasha Almanzar-Sanchez, Civil Disobedience and the First Amendment: The Subjective Constitutional Validity • 1 Vijay Anand, The Significance of Environmental Influences on an Individual’s Creativity • 12 Kiran Arshi, Divide and Conquer: The Role of Identity in Intergroup Conflicts • 25 Kaila Banguilan, Challenges in Maternal Health for Sub-Saharan Africa • 35 Courtney S. Beard, Discrimination against the Transgender Population and Recommendations for a Trans-inclusive Environment in the U.S. Military • 44 Brian Chang, CRISPR: Genetic Therapy, Enhancement, and Why It Matters • 57 Emilia Dabek, Prescription Drug Monitoring Programs for Early Detection of Drug Abuse: A Better Prognosis and Higher Survival Rate • 67 Josh Finkelstein, Night-Walkers in the Neruons • 79 Danielle Heaney, “Best Used By”: Labeling the Blame for Consumer Level Food Waste in the United States • 91 Ralston Hough, A Legalized Evil: The Usefulness of Just War Theory in Contemporary Politics • 103 Amy Hu, The Role of Pharmacogenomics in Racialized Medicine • 117 Taylor Jones, Sexuality, Sexual Identification, and Success: The Troubles and Consequences of Choosing to Stay in or Come Out of the Closet • 131 iii. -
Module 4 Diarrhoea WHO Library Cataloguing-In-Publication Data: Integrated Management of Childhood Illness: Distance Learning Course
IMCI INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS DISTANCE LEARNING COURSE Module 4 Diarrhoea WHO Library Cataloguing-in-Publication Data: Integrated Management of Childhood Illness: distance learning course. 15 booklets Contents: – Introduction, self-study modules – Module 1: general danger signs for the sick child – Module 2: The sick young infant – Module 3: Cough or difficult breathing – Module 4: Diarrhoea – Module 5: Fever – Module 6: Malnutrition and anaemia – Module 7: Ear problems – Module 8: HIV/AIDS – Module 9: Care of the well child – Facilitator guide – Pediatric HIV: supplementary facilitator guide – Implementation: introduction and roll out – Logbook – Chart book 1.Child Health Services. 2.Child Care. 3.Child Mortality – prevention and control. 4.Delivery of Health Care, Integrated. 5.Disease Management. 6.Education, Distance. 7.Teaching Material. I.World Health Organization. ISBN 978 92 4 150682 3 (NLM classification: WS 200) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. -
Infant Formula NINA R
Infant Formula NINA R. O’CONNOR, MD, Chestnut Hill Family Practice Residency, Philadelphia, Pennslyvania Although the American Academy of Pediatrics and the American Academy of Family Physicians recommend breast milk for optimal infant nutrition, many parents still choose formula as an acceptable alternative. The wide variety of available formulas is confusing to parents and physicians, but formulas can be classified according to three basic cri- teria: caloric density, carbohydrate source, and protein composition. Most infants require a term formula with iron. There is insufficient evidence to recommend supplementation with docosahexaenoic acid or arachidonic acid. Soy formulas are indicated for congenital lac- tase deficiency and galactosemia, but are not recommended for colic because of insufficient evidence of benefit. Hypoallergenic formulas calici with extensively hydrolyzed protein are effective for the treatment of S milk protein allergy and the prevention of atopic disease in high-risk ris D CH an infants. Antireflux formulas decrease emesis and regurgitation, but M I HE have not been shown to affect growth or development. Most infants N with reflux require no treatment. Family physicians can use these S. OPPE guidelines to counsel parents about infant formula, countering con- rt sumer advertising that is not evidence-based. (Am Fam Physician. 2009;79(7):565-570. Copyright © 2009 American Academy of Family Physicians.) ILLUSTRATION BY BE ▲ Patient informa- lthough the American Academy of is no evidence to recommend one brand tion: A handout on Family Physicians and the Ameri- over another; all formulas are nutritionally baby formula, written by the author of this can Academy of Pediatrics (AAP) interchangeable. -
Hydrolyzed & Plant-Based Formulas
Hydrolyzed & plant-based formulas How the game is changing Einerhand Science & Innovation Website: www.esi4u.nl E-mail: [email protected] How the infant formula landscape is changing Hydrolyzed formula Infant formula Allergen avoidance Dairy based For infants with allergies For healthy infants The prevalence of allergies is steadily rising • 30-40% of the world’s population is now affected by one or more allergic conditions1,2 • cow’s milk protein allergy is the most common cause of food allergy in infant affecting 2-7% of infants3 The most popular hypothesis that explains the rise of food allergies is the hygiene hypothesis 1. Prescott SL. J Allergy Clin Immunol. 2013;131(1):23-30. 2. Pawankar R, et al. World Allergy Organisation (WAO): White book on allergy. Wisconsin: World Allergy Organisation, 2011. 3. Fiocchi A, et al. World Allergy Organization Journal. 2010;3(4):57-161. Current dietary management based on allergen avoidance Hypo-allergenic formula Hypo-allergenic Amino formula Acids Hypo-allergenic Extensively formula hydrolysed Breast feeding Partially protein Infant formula hydrolysed protein allergen avoidance Prevention Babies at risk Moderate allergies Severe allergies How the infant formula landscape is changing Hydrolyzed formula Science drivers Tolerance induction Regulatory drivers Allergen avoidance For infants with allergies Flohr et al 2014, Allergy 69, 56-61 Science driver Tolerance induction during the neonatal window of opportunity Torow et al, J Immunol 2017; 198: 557-563 Science driver Identification of tolerogenic -
Early Infant Formula Feeding Impacts Urinary Metabolite Profile at 3
nutrients Article Early Infant Formula Feeding Impacts Urinary Metabolite Profile at 3 Months of Age Fernanda Rosa 1,2 , Kelly E. Mercer 1,2, Haixia Lin 1,2, Clark R. Sims 1,2 , Lindsay M. Pack 1, Grace Goode 1, Thomas Badger 1, Aline Andres 1,2,* and Laxmi Yeruva 1,2,3,* 1 Arkansas Children’s Nutrition Center, Little Rock, AR 72202, USA; [email protected] (F.R.); [email protected] (K.E.M.); [email protected] (H.L.); [email protected] (C.R.S.); [email protected] (L.M.P.); [email protected] (G.G.); [email protected] (T.B.) 2 Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA 3 Arkansas Children’s Research Institute, Little Rock, AR 72202, USA * Correspondence: [email protected] (A.A.); [email protected] (L.Y.); Tel.: +1-501-364-2419 (L.Y.) Received: 30 October 2020; Accepted: 18 November 2020; Published: 20 November 2020 Abstract: There is a growing consensus that nutritional programming may persist and influence risk for several chronic diseases in adulthood. In the present study, we used urinary metabolic analysis in assessing diet effects on early-life metabolism. Urine samples from healthy three-month-old infants fed human milk (HM; n = 93), cow’s milk-based infant formula [MF; n = 80], or soy protein-based infant formula (SF; n = 76) were analyzed with an untargeted metabolomics approach using GC-TOF MS. PLS-DA and ANOVA analyses were performed using MetaboAnalyst (v4.0). A total of 150 metabolites differed significantly among the feeding groups, including dietary-specific patterns of urinary metabolites of sugars, sugar alcohols, amino acids, and polyphenols. -
Acidified Infant Milk and Postbiotics
Ingredients in infant milks Acidified infant milk and postbiotics The term postbiotics refers to soluble products or metabolic by-products secreted by live bacteria (probiotics), or released after bacterial break down, such as enzymes, peptides, oligosaccharides, polysaccharides, cell surface proteins, and organic acids. It is being suggested that postbiotics may have anti-inflammatory, immunomodulatory, anti- obesogenic, antihypertensive, hypocholesterolemic, anti-proliferative, and antioxidant activities (Aguilar-Toalâ et al, 2018). These suggested properties could mean that postbiotics might contribute to the improvement of host health by improving specific physiological functions. Currently mechanisms of action for postbiotics have not been entirely elucidated. The presence of postbiotics in infant milks is not a new development as 'acidified' infant milks produced by fermentation with lactic acid producing bacteria have been available in other European countries such as France and in African countries for many years. They contain postbiotics and have been described as: “Infant and follow-on formulae that have been fermented with lactic acid-producing bacteria during the production process, but do not contain live bacteria in the final product due to inactivation of the fermenting bacteria by heat treatment or other means". (ESPGHAN, 2007). They have typically been marketed as being useful in preventing a range of gastrointestinal symptoms and, in particular, in preventing diarrhoeal disease. Despite widespread use globally, there is little published data available to support their use. There are a small number of studies that have investigated the effects of fermented infant milks on diarrhoeal disease amongst infants who are receiving complementary foods. Brunser et al,1989 showed a reduction in the incidence of diarrhoea as well as a lower proportion of days with diarrhoea and shorter duration of episodes in Chilean children fed acidified Nestlé Pelargon formula, compared to those receiving the same formula but non acidified. -
Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants
STANDARD FOR INFANT FORMULA AND FORMULAS FOR SPECIAL MEDICAL PURPOSES INTENDED FOR INFANTS CODEX STAN 72 – 1981 Adopted as a worldwide Standard in 1981. Amendment: 1983, 1985, 1987, 2011 and 2015. Revision: 2007. Formerly CAC/RS 72-1972. CODEX STAN 72 – 1981 2 SECTION A: REVISED STANDARD FOR INFANT FORMULA PREAMBLE This standard is divided into two sections. Section A refers to Infant Formula, and Section B deals with Formulas for Special Medical Purposes Intended for Infants. 1. SCOPE 1.1 This section of the Standard applies to infant formula in liquid or powdered form intended for use, where necessary, as a substitute for human milk in meeting the normal nutritional requirements of infants. 1.2 This section of the Standard contains compositional, quality and safety requirements for Infant Formula. 1.3 Only products that comply with the criteria laid down in the provisions of this section of this Standard would be accepted for marketing as infant formula. No product other than infant formula may be marketed or otherwise represented as suitable for satisfying by itself the nutritional requirements of normal healthy infants during the first months of life. 1.4 The application of this section of the Standard should take into account the recommendations made in the International Code of Marketing of Breast-milk Substitutes (1981), the Global Strategy for Infant and Young Child Feeding and World Health Assembly resolution WHA54.2 (2001). 2. DESCRIPTION 2.1 Product Definition 2.1.1 Infant formula means a breast-milk substitute specially manufactured to satisfy, by itself, the nutritional requirements of infants during the first months of life up to the introduction of appropriate complementary feeding. -
Vegetarian and Vegan Weaning of the Infant: How Common and How Evidence-Based? a Population-Based Survey and Narrative Review
International Journal of Environmental Research and Public Health Review Vegetarian and Vegan Weaning of the Infant: How Common and How Evidence-Based? A Population-Based Survey and Narrative Review Maria Elisabetta Baldassarre 1,* , Raffaella Panza 1,* , Ilaria Farella 2, Domenico Posa 1, Manuela Capozza 1, Antonio Di Mauro 1 and Nicola Laforgia 1 1 Department of Biomedical Science and Human Oncology, Neonatology and Neonatal Intensive Care Unit, “Aldo Moro” University of Bari, 70100 Bari, Italy; [email protected] (D.P.); [email protected] (M.C.); [email protected] (A.D.M.); [email protected] (N.L.) 2 Department of Pediatrics, Queen Fabiola Children’s University Hospital, 1020 Bruxelles, Belgium; [email protected] * Correspondence: [email protected] (M.E.B.); raff[email protected] (R.P.); Tel.: +32-96114818 (M.E.B.); +39-3496965060 (R.P.); Fax: +39-0805592991 (M.E.B. & R.P.) Received: 17 June 2020; Accepted: 2 July 2020; Published: 5 July 2020 Abstract: Background: Vegetarian and vegan weaning have increasing popularity among parents and families. However, if not correctly managed, they may lead to wrong feeding regimens, causing severe nutritional deficiencies requiring specific nutritional support or even the need for hospitalization. Aim: To assess the prevalence of vegetarian and vegan weaning among Italian families and to provide an up-to-date narrative review of supporting evidence. Materials and methods: We investigated 360 Italian families using a 40-item questionnaire. The narrative review was conducted searching scientific databases for articles reporting on vegetarian and vegan weaning. Results: 8.6% of mothers follow an alternative feeding regimen and 9.2% of infants were weaned according to a vegetarian or vegan diet. -
CCFP Approved Formula List*
CCFP Approved Formula List* *If formula is served to infants 13 months of age and older, a medical statement is required for reimbursement. * Please note breast milk is encouraged and reimbursable until any age the mother/child are ready to be weaned. In order to approve an Infant Formula, it must meet the following three criteria: 1. Infant formula must be iron-fortified. This means it contains at least 1 milligram (mg) iron per 100 kilocalorie (calorie) serving, when prepared in accordance with label directions. 2. Infant formula must be regulated by and meet the nutrient specifications set by the FDA. This means that formula purchased outside the U.S., is not likely to be regulated by the FDA and is therefore not creditable. 3. Infant formula must not be found on the “FDA Exempt Infant Formula List”. If found on this list, the formula will only be allowed with a medical statement signed by a licensed physician. The following iron-fortified infant formulas are approved and do not require a medical statement. Infant Formulas Milk-based Earth’s Best Organic Gerber Good Start Gentle Earth’s Best Organic Sensitivity Gerber Good Start Gentle for Supplementing Enfamil AR Gerber Good Start Soothe Enfamil Gentlease Gerber Graduates Gentle (9-24 months) Enfamil Infant Gerber Graduates Soothe (9-24 months) Enfamil Newborn Similac Advance stage 1 (0-12months) Enfamil Reguline Similac Advance stage 2 (6-12 months) Enfamil for Supplementing Similac Advance Organic Enfamil Enfagrow Toddler Transition (9-18 months) Similac Sensitive Enfamil Enfagrow -
Sudden Unexplained Infant Death Investigation Manual, Chapter 2
24 SUDDEN, UNEXPLAINED INFANT DEATH INVESTIGATION 2 c h a p t e r Kay Tomashek, M.D., M.P.H. Sarah Blanding, M.P.H., R.D. Laura Crandall, M.A., P.T., N.C.S. CHAPTER 2 INFANT GROWTH AND DEVELOPMENT SECTION 1: INFANT DEATH INVESTIGATION FOUNDATION SKILLS 25 Infant Growth and Development Birth to One Year of Age Unit 3: Infant Growth Unit 4: Infant Developmental Milestones Unit 5: Infant Feeding, Diet, and Risks Unlike most decedents encountered by death investigators, infants have limited ability to put themselves in harm's way. This chapter covers basic human growth and development, and dietary issues as applicable to infants from birth to one year of age, and information and technologies that can assist the investigator in evaluating the plausibility of witness accounts and observations as they pertain to infant abilities and purported actions prior to death. CHAPTER 2 INFANT GROWTH AND DEVELOPMENT 26 SUDDEN, UNEXPLAINED INFANT DEATH INVESTIGATION OVERVIEW One of the most difficult tasks the infant death investigator has to perform is sorting the numerous details each case produces. Often, these details are part of a witness account of infant activity prior to the incident that preceded the death. Investigators must understand normal infant abilities—based on age—and be able to correlate these with those activities reported by witnesses. This chapter details normal, and abnormal infant growth and development. The student will also be introduced to the most common growth charts and developmental screening tests used in the United States. SUPPORT MATERIALS In addition to the SUIDI Reporting Form or jursidictionally approved equivalent, the following support materials are suggested: 1.